Company intelligence / Profile preview

Vision+ Capital

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Vision+ Capital is a prominent venture capital firm headquartered in Hangzhou, China, established in 2015 by John Wu, a co-founder and former CTO of Alibaba Group. The firm focuses on early-stage investments in high-growth sectors, specifically digital healthcare, frontier technology, and enterprise services. Within the life sciences and healthcare domain, Vision+ Capital targets innovative companies utilizing artificial intelligence, big data, and digital platforms to transform medical services and drug discovery. The firm manages both USD and RMB funds, positioning itself as a bridge between technology and traditional industries. Its portfolio includes significant players in the Chinese digital health ecosystem, reflecting its commitment to tech-driven healthcare solutions.

Industry: Investors

Beyond the preview

Go deeper on Vision+ Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vision+ Capital.

Explore the full profile